0.9954

5.24% -0.0546

Bluejay Diagnostics Inc (BJDX)

Overview News Price History Financials Why BJDX Down? Discussions Forecast Stock Split

Bluejay Diagnostics Inc stock is traded at $0.9954, with a volume of 328.89K. It is down -5.24% in the last 24 hours and down -31.38% over the past month. Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Previous Close:

$1.05

Open:

$1.04

24h Volume:

328.89K

Relative Volume:

0.06

Market Cap:

$1.03M

Revenue:

Net Income/Loss:

$-6.90M

P/E Ratio:

-0.071

EPS:

-14.0152

Net Cash Flow:

$-6.65M

1W Performance:

+0.79%

1M Performance:

-31.38%

6M Performance:

-63.01%

1Y Performance:

-81.71%

1-Day Range:

$0.9762

$1.0497

1-Week Range:

$0.95

$1.10

52-Week Range:

$0.83

$16.68

Bluejay Diagnostics Inc Stock (BJDX) Company Profile

Name

Bluejay Diagnostics Inc

Sector

Healthcare (1089)

Industry

Medical Devices (141)

Phone

(978) 631-0152

Address

360 MASSACHUSETTS AVENUE, SUITE 203, ACTON

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

BJDX's Discussions on Twitter

Compare BJDX vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BJDX Bluejay Diagnostics Inc	0.9954	1.09M	0	-6.90M	-6.65M	-14.02
ABT Abbott Laboratories	110.11	192.51B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	332.33	130.11B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	90.67	116.83B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	51.55	75.11B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	90.83	52.80B	6.30B	1.07B	1.09B	1.8406

Bluejay Diagnostics Inc Stock (BJDX) Latest News

Aug 14, 2026

Armistice Capital discloses 9.99% Bluejay Diagnostics (BJDX) position in Schedule 13G - Stock Titan

Aug 14, 2026

Aug 13, 2026

Bluejay Diagnostics (BJDX) investor group discloses 9.99% ownership with warrants - Stock Titan

Aug 13, 2026

Form 8K Bluejay Diagnostics Inc For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026

Bluejay Advances Symphony Platform, Strengthens Cash Position - TipRanks

Aug 13, 2026

Form 8K Bluejay Diagnostics Inc For: 13 August - Investing.com India

Aug 13, 2026

Bluejay Diagnostics Q2 Results: EPS loss narrows 80% YoY to $(1.12) - scanx.trade

Aug 13, 2026

Bluejay Diagnostics completes enrollment in sepsis test study - Investing.com

Aug 13, 2026

Bluejay Diagnostics Completes Enrollment in SYMON-II Pivotal Study, Advances Toward 510(k) Submission and Commercialization - quiverquant.com

Aug 13, 2026

Bluejay completes 750-patient study enrollment for Symphony IL-6 - Stock Titan

Aug 13, 2026

Aug 12, 2026

Bluejay Diagnostics, Inc. Q2 2026: Net loss $(2.32M), EPS $(1.12) — 10-Q Summary - TradingView

Aug 12, 2026

Bluejay Diagnostics (BJDX) warns on going concern and Nasdaq listing risk - Stock Titan

Aug 12, 2026

Aug 07, 2026